Zeke Capital Advisors’s Biogen BIIB Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q2
Sell
-1,141
Closed -$240K 487
2022
Q1
$240K Buy
+1,141
New +$248K 0.01% 434
2020
Q1
Sell
-1,048
Closed -$311K 266
2019
Q4
$311K Sell
1,048
-13
-1% -$3.61K 0.03% 459
2019
Q3
$247K Sell
1,061
-3,446
-76% -$802K 0.02% 483
2019
Q2
$1.05M Buy
4,507
+23
+0.5% +$5.31K 0.1% 169
2019
Q1
$1.06M Sell
4,484
-210
-4% -$66.1K 0.1% 169
2018
Q4
$1.41M Sell
4,694
-3,562
-43% -$1.14M 0.14% 138
2018
Q3
$2.92M Hold
8,256
0.24% 71
2018
Q2
$2.4M Buy
8,256
+4,461
+118% +$1.25M 0.22% 78
2018
Q1
$1.04M Sell
3,795
-1,659
-30% -$515K 0.1% 190
2017
Q4
$1.74M Buy
5,454
+1,689
+45% +$542K 0.18% 94
2017
Q3
$1.18M Buy
3,765
+2,340
+164% +$693K 0.16% 102
2017
Q2
$387K Sell
1,425
-59
-4% -$15.6K 0.08% 162
2017
Q1
$406K Buy
1,484
+448
+43% +$127K 0.09% 144
2016
Q4
$294K Buy
+1,036
New +$307K 0.09% 138

Other funds holding BIIB